PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene Symbol | Gene ID | Gene Info |
---|---|---|
fli1b
|
ENSDARG00000040080 | Fli-1 proto-oncogene, ETS transcription factor b |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
fli1b | dr11_v1_chr16_+_42018041_42018042 | 0.77 | 1.3e-19 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_+_38285671 | 30.03 |
ENSDART00000061432
|
ccl38a.4
|
chemokine (C-C motif) ligand 38, duplicate 4 |
chr21_+_25765734 | 21.17 |
ENSDART00000021664
|
cldnb
|
claudin b |
chr14_-_40797117 | 20.52 |
ENSDART00000122369
|
elf1
|
E74-like ETS transcription factor 1 |
chr18_-_48517040 | 20.43 |
ENSDART00000143645
|
kcnj1a.3
|
potassium inwardly-rectifying channel, subfamily J, member 1a, tandem duplicate 3 |
chr1_-_37383539 | 20.31 |
ENSDART00000127579
|
scpp1
|
secretory calcium-binding phosphoprotein 1 |
chr8_+_3379815 | 20.02 |
ENSDART00000155995
|
FUT9 (1 of many)
|
zgc:136963 |
chr18_-_48500545 | 18.74 |
ENSDART00000058989
ENSDART00000098450 |
kcnj1a.6
kcnj1a.5
|
potassium inwardly-rectifying channel, subfamily J, member 1a, tandem duplicate 6 potassium inwardly-rectifying channel, subfamily J, member 1a, tandem duplicate 5 |
chr13_+_30696286 | 17.69 |
ENSDART00000192411
|
cxcl18a.1
|
chemokine (C-X-C motif) ligand 18a, duplicate 1 |
chr23_-_10175898 | 16.71 |
ENSDART00000146185
|
krt5
|
keratin 5 |
chr17_-_37395460 | 15.91 |
ENSDART00000148160
ENSDART00000075975 |
crip1
|
cysteine-rich protein 1 |
chr1_-_37383741 | 15.48 |
ENSDART00000193155
ENSDART00000191887 ENSDART00000189077 |
scpp1
|
secretory calcium-binding phosphoprotein 1 |
chr22_+_5687615 | 15.18 |
ENSDART00000133241
ENSDART00000019854 ENSDART00000138102 |
dnase1l4.2
|
deoxyribonuclease 1 like 4, tandem duplicate 2 |
chr15_-_2652640 | 14.64 |
ENSDART00000146094
|
cldnf
|
claudin f |
chr21_+_22985078 | 14.12 |
ENSDART00000156491
|
lpar6b
|
lysophosphatidic acid receptor 6b |
chr1_-_45157243 | 14.00 |
ENSDART00000131882
|
mucms1
|
mucin, multiple PTS and SEA group, member 1 |
chr8_-_31107537 | 13.97 |
ENSDART00000098925
|
vgll4l
|
vestigial like 4 like |
chr16_+_35401543 | 13.90 |
ENSDART00000171608
|
rab42b
|
RAB42, member RAS oncogene family |
chr6_-_8480815 | 13.77 |
ENSDART00000162300
|
rasal3
|
RAS protein activator like 3 |
chr12_-_35830625 | 13.70 |
ENSDART00000180028
|
CU459056.1
|
|
chr14_-_9128919 | 13.69 |
ENSDART00000108641
|
sh2d1ab
|
SH2 domain containing 1A duplicate b |
chr15_+_15779184 | 13.42 |
ENSDART00000156902
|
si:ch211-33e4.2
|
si:ch211-33e4.2 |
chr1_-_29658721 | 13.14 |
ENSDART00000132063
|
si:dkey-1h24.6
|
si:dkey-1h24.6 |
chr8_-_7093507 | 13.09 |
ENSDART00000045669
|
si:dkey-222n6.2
|
si:dkey-222n6.2 |
chr11_+_8129536 | 12.78 |
ENSDART00000158112
ENSDART00000011183 |
prkacba
|
protein kinase, cAMP-dependent, catalytic, beta a |
chr15_+_20239141 | 12.73 |
ENSDART00000101152
ENSDART00000152473 |
spint2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr15_+_11883804 | 12.66 |
ENSDART00000163255
|
gpr184
|
G protein-coupled receptor 184 |
chr11_+_25278772 | 12.47 |
ENSDART00000188630
|
cyldb
|
cylindromatosis (turban tumor syndrome), b |
chr25_+_34014523 | 12.17 |
ENSDART00000182856
|
anxa2a
|
annexin A2a |
chr15_+_28410664 | 12.05 |
ENSDART00000132028
ENSDART00000057697 ENSDART00000057257 |
pitpnaa
|
phosphatidylinositol transfer protein, alpha a |
chr2_+_48282590 | 12.02 |
ENSDART00000035338
|
lpar5a
|
lysophosphatidic acid receptor 5a |
chr20_+_25340814 | 11.84 |
ENSDART00000063028
|
ctgfa
|
connective tissue growth factor a |
chr16_+_11818126 | 11.77 |
ENSDART00000145727
|
cxcr3.2
|
chemokine (C-X-C motif) receptor 3, tandem duplicate 2 |
chr18_-_48550426 | 11.53 |
ENSDART00000145189
|
kcnj1a.1
|
potassium inwardly-rectifying channel, subfamily J, member 1a, tandem duplicate 1 |
chr16_-_39570832 | 11.49 |
ENSDART00000039832
|
tgfbr2b
|
transforming growth factor beta receptor 2b |
chr6_+_30668098 | 11.49 |
ENSDART00000112294
|
ttc22
|
tetratricopeptide repeat domain 22 |
chr3_+_29510818 | 11.48 |
ENSDART00000055407
ENSDART00000193743 ENSDART00000123619 |
rac2
|
Rac family small GTPase 2 |
chr5_-_42272517 | 11.48 |
ENSDART00000137692
ENSDART00000164363 |
si:ch211-207c6.2
|
si:ch211-207c6.2 |
chr9_+_2499627 | 11.17 |
ENSDART00000160782
|
wipf1a
|
WAS/WASL interacting protein family, member 1a |
chr12_+_22576404 | 11.15 |
ENSDART00000172053
|
capgb
|
capping protein (actin filament), gelsolin-like b |
chr21_+_30794351 | 10.96 |
ENSDART00000139486
|
zgc:158225
|
zgc:158225 |
chr22_-_17729778 | 10.89 |
ENSDART00000192132
|
si:ch73-63e15.2
|
si:ch73-63e15.2 |
chr15_+_17756113 | 10.89 |
ENSDART00000155197
|
si:ch211-213d14.2
|
si:ch211-213d14.2 |
chr14_+_41345175 | 10.85 |
ENSDART00000086104
|
nox1
|
NADPH oxidase 1 |
chr5_+_37087583 | 10.85 |
ENSDART00000049900
|
tagln2
|
transgelin 2 |
chr7_+_39706004 | 10.61 |
ENSDART00000161856
|
ccl36.1
|
chemokine (C-C motif) ligand 36, duplicate 1 |
chr9_-_31108285 | 10.52 |
ENSDART00000003193
|
gpr183a
|
G protein-coupled receptor 183a |
chr21_-_34972872 | 10.50 |
ENSDART00000023838
|
lipia
|
lipase, member Ia |
chr7_+_20017211 | 10.38 |
ENSDART00000100808
|
bcl6b
|
B-cell CLL/lymphoma 6, member B |
chr5_+_46277593 | 10.25 |
ENSDART00000045598
|
zgc:110626
|
zgc:110626 |
chr15_+_36054864 | 10.15 |
ENSDART00000156697
|
col4a3
|
collagen, type IV, alpha 3 |
chr6_-_29195642 | 10.04 |
ENSDART00000078625
|
dpt
|
dermatopontin |
chr18_-_6982499 | 9.98 |
ENSDART00000101525
|
si:dkey-266m15.6
|
si:dkey-266m15.6 |
chr3_+_22377312 | 9.96 |
ENSDART00000155597
|
arhgap27l
|
Rho GTPase activating protein 27, like |
chr23_+_42813415 | 9.96 |
ENSDART00000055577
|
myl9a
|
myosin, light chain 9a, regulatory |
chr16_+_38201840 | 9.96 |
ENSDART00000044971
|
myo1eb
|
myosin IE, b |
chr2_+_22495274 | 9.92 |
ENSDART00000167915
|
lrrc8da
|
leucine rich repeat containing 8 VRAC subunit Da |
chr1_+_36674584 | 9.89 |
ENSDART00000186772
ENSDART00000192274 |
ednraa
|
endothelin receptor type Aa |
chr7_-_22981796 | 9.84 |
ENSDART00000167565
|
si:dkey-171c9.3
|
si:dkey-171c9.3 |
chr19_-_13808630 | 9.73 |
ENSDART00000166895
ENSDART00000187670 |
ctgfb
|
connective tissue growth factor b |
chr1_-_40735381 | 9.70 |
ENSDART00000093269
|
zgc:153642
|
zgc:153642 |
chr3_-_32603191 | 9.69 |
ENSDART00000150997
|
si:ch73-248e21.7
|
si:ch73-248e21.7 |
chr7_+_17816006 | 9.68 |
ENSDART00000080834
|
eml3
|
echinoderm microtubule associated protein like 3 |
chr22_-_28650442 | 9.61 |
ENSDART00000019846
|
col8a1b
|
collagen, type VIII, alpha 1b |
chr5_+_30741730 | 9.45 |
ENSDART00000098246
ENSDART00000186992 ENSDART00000182533 |
ftr83
|
finTRIM family, member 83 |
chr16_-_51271962 | 9.40 |
ENSDART00000164021
ENSDART00000046420 |
serpinb1l1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1 |
chr7_+_19482084 | 9.27 |
ENSDART00000173873
|
si:ch211-212k18.7
|
si:ch211-212k18.7 |
chr21_-_25295087 | 9.25 |
ENSDART00000087910
ENSDART00000147860 |
st14b
|
suppression of tumorigenicity 14 (colon carcinoma) b |
chr5_-_26834511 | 9.18 |
ENSDART00000136713
ENSDART00000192932 ENSDART00000113246 |
si:ch211-102c2.4
|
si:ch211-102c2.4 |
chr15_+_17251191 | 9.15 |
ENSDART00000156587
|
si:ch73-223p23.2
|
si:ch73-223p23.2 |
chr4_+_14957360 | 9.12 |
ENSDART00000002770
ENSDART00000111882 ENSDART00000148292 |
tspan33a
|
tetraspanin 33a |
chr15_-_43284021 | 9.02 |
ENSDART00000041677
|
serpine2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr3_+_3545825 | 8.97 |
ENSDART00000109060
|
CR589947.1
|
|
chr24_-_20192996 | 8.93 |
ENSDART00000011143
|
myd88
|
myeloid differentiation primary response 88 |
chr1_+_1904419 | 8.91 |
ENSDART00000142874
|
si:ch211-132g1.4
|
si:ch211-132g1.4 |
chr2_-_37862380 | 8.89 |
ENSDART00000186005
|
si:ch211-284o19.8
|
si:ch211-284o19.8 |
chr3_+_24655643 | 8.87 |
ENSDART00000126148
|
zmp:0000000912
|
zmp:0000000912 |
chr8_-_13029297 | 8.84 |
ENSDART00000144305
|
dennd2da
|
DENN/MADD domain containing 2Da |
chr9_-_34368842 | 8.84 |
ENSDART00000140349
|
cd247l
|
CD247 antigen like |
chr10_+_8875195 | 8.82 |
ENSDART00000141045
|
itga2.3
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), tandem duplicate 3 |
chr10_-_20650302 | 8.77 |
ENSDART00000142028
ENSDART00000064662 |
rassf2b
|
Ras association (RalGDS/AF-6) domain family member 2b |
chr12_-_28983584 | 8.76 |
ENSDART00000112374
|
zgc:171713
|
zgc:171713 |
chr15_+_22014029 | 8.76 |
ENSDART00000079504
|
ankk1
|
ankyrin repeat and kinase domain containing 1 |
chr16_-_26676685 | 8.74 |
ENSDART00000103431
|
esrp1
|
epithelial splicing regulatory protein 1 |
chr16_+_3982590 | 8.71 |
ENSDART00000149295
|
zc3h12a
|
zinc finger CCCH-type containing 12A |
chr16_+_42018041 | 8.59 |
ENSDART00000134010
ENSDART00000102789 |
fli1b
|
Fli-1 proto-oncogene, ETS transcription factor b |
chr16_-_51299061 | 8.58 |
ENSDART00000148677
|
serpinb1l4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 4 |
chr23_-_14825450 | 8.58 |
ENSDART00000188009
|
sla2
|
Src-like-adaptor 2 |
chr14_-_11456724 | 8.57 |
ENSDART00000110424
|
si:ch211-153b23.4
|
si:ch211-153b23.4 |
chr19_-_325584 | 8.55 |
ENSDART00000134266
|
gpd1c
|
glycerol-3-phosphate dehydrogenase 1c |
chr17_+_31363000 | 8.53 |
ENSDART00000062900
|
itpka
|
inositol-trisphosphate 3-kinase A |
chr20_-_26066020 | 8.52 |
ENSDART00000078559
|
myct1a
|
myc target 1a |
chr1_-_18848955 | 8.43 |
ENSDART00000109294
ENSDART00000146410 |
zgc:195282
|
zgc:195282 |
chr14_+_22076596 | 8.41 |
ENSDART00000106147
ENSDART00000100278 ENSDART00000131489 |
slc43a1a
|
solute carrier family 43 (amino acid system L transporter), member 1a |
chr9_+_35860975 | 8.41 |
ENSDART00000134447
|
rcan1a
|
regulator of calcineurin 1a |
chr17_-_2039511 | 8.37 |
ENSDART00000160223
|
spint1a
|
serine peptidase inhibitor, Kunitz type 1 a |
chr3_+_53240562 | 8.29 |
ENSDART00000031234
|
stxbp2
|
syntaxin binding protein 2 |
chr22_-_13165186 | 8.13 |
ENSDART00000105762
|
ahr2
|
aryl hydrocarbon receptor 2 |
chr17_-_21368775 | 8.11 |
ENSDART00000058027
|
shtn1
|
shootin 1 |
chr17_-_7733037 | 8.04 |
ENSDART00000064657
|
stx11a
|
syntaxin 11a |
chr11_+_22109887 | 7.99 |
ENSDART00000122136
|
MDFI
|
si:dkey-91m3.1 |
chr1_+_1896737 | 7.96 |
ENSDART00000152442
|
si:ch211-132g1.6
|
si:ch211-132g1.6 |
chr24_-_6078222 | 7.92 |
ENSDART00000146830
|
apbb1ip
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
chr16_-_10316359 | 7.91 |
ENSDART00000104025
|
flot1b
|
flotillin 1b |
chr5_+_20421539 | 7.87 |
ENSDART00000164499
|
selplg
|
selectin P ligand |
chr25_+_35553542 | 7.86 |
ENSDART00000113723
|
spi1a
|
Spi-1 proto-oncogene a |
chr12_+_20552190 | 7.82 |
ENSDART00000113224
|
gna13a
|
guanine nucleotide binding protein (G protein), alpha 13a |
chr8_-_14209852 | 7.80 |
ENSDART00000005359
|
def6a
|
differentially expressed in FDCP 6a homolog (mouse) |
chr11_-_18384534 | 7.79 |
ENSDART00000156499
|
prkcdb
|
protein kinase C, delta b |
chr20_-_21672970 | 7.69 |
ENSDART00000133286
|
si:ch211-207i1.2
|
si:ch211-207i1.2 |
chr8_-_30242706 | 7.61 |
ENSDART00000139864
ENSDART00000143809 |
zgc:162939
|
zgc:162939 |
chr1_+_1915967 | 7.57 |
ENSDART00000131463
|
si:ch211-132g1.1
|
si:ch211-132g1.1 |
chr8_-_18010735 | 7.52 |
ENSDART00000125014
|
acot11b
|
acyl-CoA thioesterase 11b |
chr6_+_2030703 | 7.52 |
ENSDART00000109679
ENSDART00000187502 ENSDART00000191165 ENSDART00000187544 |
quo
|
quattro |
chr11_+_21137948 | 7.47 |
ENSDART00000110673
|
il10
|
interleukin 10 |
chr3_-_36364903 | 7.43 |
ENSDART00000028883
|
gna13b
|
guanine nucleotide binding protein (G protein), alpha 13b |
chr13_+_32144370 | 7.42 |
ENSDART00000020270
|
osr1
|
odd-skipped related transciption factor 1 |
chr13_+_39532050 | 7.41 |
ENSDART00000019379
|
marveld1
|
MARVEL domain containing 1 |
chr14_-_36799280 | 7.37 |
ENSDART00000168615
|
rnf130
|
ring finger protein 130 |
chr18_-_40856354 | 7.34 |
ENSDART00000098865
|
vaspb
|
vasodilator stimulated phosphoprotein b |
chr7_+_17816470 | 7.32 |
ENSDART00000173807
|
eml3
|
echinoderm microtubule associated protein like 3 |
chr16_-_9802449 | 7.31 |
ENSDART00000081208
|
tapbpl
|
TAP binding protein (tapasin)-like |
chr9_-_9419704 | 7.28 |
ENSDART00000138996
|
si:ch211-214p13.9
|
si:ch211-214p13.9 |
chr11_-_29916607 | 7.28 |
ENSDART00000138912
ENSDART00000079152 |
vegfd
|
vascular endothelial growth factor D |
chr5_-_26879302 | 7.27 |
ENSDART00000098571
ENSDART00000139086 |
zgc:64051
|
zgc:64051 |
chr14_+_34501245 | 7.23 |
ENSDART00000131424
|
lcp2b
|
lymphocyte cytosolic protein 2b |
chr13_-_42749916 | 7.21 |
ENSDART00000140019
|
capn2a
|
calpain 2, (m/II) large subunit a |
chr22_-_18164671 | 7.17 |
ENSDART00000014057
|
rfxank
|
regulatory factor X-associated ankyrin-containing protein |
chr25_+_14109626 | 7.14 |
ENSDART00000109883
|
actc1c
|
actin, alpha, cardiac muscle 1c |
chr24_-_40726073 | 7.07 |
ENSDART00000168100
|
smyhc2
|
slow myosin heavy chain 2 |
chr3_+_3598555 | 7.07 |
ENSDART00000191152
|
CR589947.3
|
|
chr17_+_10242166 | 6.99 |
ENSDART00000170420
|
clec14a
|
C-type lectin domain containing 14A |
chr10_-_15849027 | 6.99 |
ENSDART00000184682
|
tjp2a
|
tight junction protein 2a (zona occludens 2) |
chr7_-_26601307 | 6.99 |
ENSDART00000188934
|
plscr3b
|
phospholipid scramblase 3b |
chr9_-_11550711 | 6.95 |
ENSDART00000093343
|
fev
|
FEV (ETS oncogene family) |
chr8_+_25342896 | 6.90 |
ENSDART00000129032
|
CR847543.1
|
|
chr5_-_41049690 | 6.88 |
ENSDART00000174936
ENSDART00000135030 |
pdzd2
|
PDZ domain containing 2 |
chr7_+_20563305 | 6.88 |
ENSDART00000169661
|
si:dkey-19b23.10
|
si:dkey-19b23.10 |
chr5_-_34616599 | 6.82 |
ENSDART00000050271
ENSDART00000097975 |
hexb
|
hexosaminidase B (beta polypeptide) |
chr7_-_51461649 | 6.82 |
ENSDART00000193947
ENSDART00000174328 |
arhgap36
|
Rho GTPase activating protein 36 |
chr16_+_38277339 | 6.78 |
ENSDART00000085143
|
bnipl
|
BCL2 interacting protein like |
chr14_-_34605607 | 6.77 |
ENSDART00000191608
|
afap1l1a
|
actin filament associated protein 1-like 1a |
chr9_+_13985567 | 6.72 |
ENSDART00000102296
|
cd28
|
CD28 molecule |
chr13_-_15986871 | 6.72 |
ENSDART00000189394
|
ikzf1
|
IKAROS family zinc finger 1 (Ikaros) |
chr18_+_27598755 | 6.71 |
ENSDART00000193808
|
cd82b
|
CD82 molecule b |
chr3_+_27713610 | 6.67 |
ENSDART00000019004
|
arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr11_+_24313931 | 6.64 |
ENSDART00000017599
ENSDART00000166045 |
rem1
|
RAS (RAD and GEM)-like GTP-binding 1 |
chr8_+_21254192 | 6.57 |
ENSDART00000167718
|
itpr3
|
inositol 1,4,5-trisphosphate receptor, type 3 |
chr8_-_19975087 | 6.54 |
ENSDART00000182220
|
lpxn
|
leupaxin |
chr15_-_551177 | 6.53 |
ENSDART00000066774
ENSDART00000154617 |
tagln
|
transgelin |
chr19_-_12404590 | 6.50 |
ENSDART00000103703
|
ftr56
|
finTRIM family, member 56 |
chr9_+_14010823 | 6.48 |
ENSDART00000143837
|
si:ch211-67e16.3
|
si:ch211-67e16.3 |
chr16_-_51253925 | 6.47 |
ENSDART00000050644
|
serpinb14
|
serpin peptidase inhibitor, clade B (ovalbumin), member 14 |
chr3_+_42090418 | 6.45 |
ENSDART00000109392
ENSDART00000157164 |
snx8a
|
sorting nexin 8a |
chr2_-_24069331 | 6.42 |
ENSDART00000156972
ENSDART00000181691 ENSDART00000157041 |
slc12a7a
|
solute carrier family 12 (potassium/chloride transporter), member 7a |
chr24_-_11069237 | 6.37 |
ENSDART00000127398
|
CR753886.1
|
|
chr1_-_8653385 | 6.31 |
ENSDART00000193041
|
actb1
|
actin, beta 1 |
chr7_+_26545502 | 6.29 |
ENSDART00000140528
|
tnk1
|
tyrosine kinase, non-receptor, 1 |
chr14_+_6287871 | 6.28 |
ENSDART00000105344
|
tbc1d2
|
TBC1 domain family, member 2 |
chr5_+_27898226 | 6.27 |
ENSDART00000098604
ENSDART00000180251 |
adam28
|
ADAM metallopeptidase domain 28 |
chr22_-_18164835 | 6.25 |
ENSDART00000143189
|
rfxank
|
regulatory factor X-associated ankyrin-containing protein |
chr16_+_53125918 | 6.21 |
ENSDART00000102170
|
CABZ01053976.1
|
|
chr19_+_43297546 | 6.20 |
ENSDART00000168002
|
laptm5
|
lysosomal protein transmembrane 5 |
chr5_-_69716501 | 6.19 |
ENSDART00000158956
|
mob1a
|
MOB kinase activator 1A |
chr18_-_22094102 | 6.17 |
ENSDART00000100904
|
pard6a
|
par-6 family cell polarity regulator alpha |
chr19_+_3849378 | 6.15 |
ENSDART00000166218
ENSDART00000159228 |
oscp1a
|
organic solute carrier partner 1a |
chr3_+_34877066 | 6.15 |
ENSDART00000161963
|
itga3a
|
integrin, alpha 3a |
chr15_+_36096689 | 6.13 |
ENSDART00000049849
|
col4a3
|
collagen, type IV, alpha 3 |
chr9_+_54179306 | 6.07 |
ENSDART00000189829
|
tmsb4x
|
thymosin, beta 4 x |
chr11_+_25139495 | 6.06 |
ENSDART00000168368
|
si:ch211-25d12.7
|
si:ch211-25d12.7 |
chr3_-_40528333 | 6.05 |
ENSDART00000193047
|
actb2
|
actin, beta 2 |
chr6_-_55423220 | 6.04 |
ENSDART00000158929
|
ctsa
|
cathepsin A |
chr3_-_36839115 | 6.03 |
ENSDART00000154553
|
ramp2
|
receptor (G protein-coupled) activity modifying protein 2 |
chr19_-_34927201 | 5.99 |
ENSDART00000076518
|
sla1
|
Src-like-adaptor 1 |
chr22_-_31517300 | 5.99 |
ENSDART00000164799
|
slc6a6b
|
solute carrier family 6 (neurotransmitter transporter), member 6b |
chr7_+_11543999 | 5.99 |
ENSDART00000173676
|
il16
|
interleukin 16 |
chr8_-_19280856 | 5.98 |
ENSDART00000100473
|
zgc:77486
|
zgc:77486 |
chr3_+_24641489 | 5.94 |
ENSDART00000055590
ENSDART00000186635 |
zgc:113411
|
zgc:113411 |
chr20_-_463786 | 5.91 |
ENSDART00000032212
|
frk
|
fyn-related Src family tyrosine kinase |
chr9_+_13999620 | 5.87 |
ENSDART00000143229
|
cd28l
|
cd28-like molecule |
chr14_-_34059681 | 5.82 |
ENSDART00000003993
|
itk
|
IL2 inducible T cell kinase |
chr22_+_20710434 | 5.81 |
ENSDART00000135521
|
peak3
|
PEAK family member 3 |
chr4_-_22310956 | 5.79 |
ENSDART00000162585
|
hcls1
|
hematopoietic cell-specific Lyn substrate 1 |
chr5_+_21181047 | 5.77 |
ENSDART00000088506
|
arhgap25
|
Rho GTPase activating protein 25 |
chr23_+_26009266 | 5.76 |
ENSDART00000054025
|
si:dkey-78k11.9
|
si:dkey-78k11.9 |
chr17_+_33453689 | 5.76 |
ENSDART00000156894
|
rin3
|
Ras and Rab interactor 3 |
chr18_+_49969568 | 5.75 |
ENSDART00000126916
|
mob2b
|
MOB kinase activator 2b |
chr18_-_16801033 | 5.75 |
ENSDART00000100100
|
admb
|
adrenomedullin b |
chr9_+_23772516 | 5.72 |
ENSDART00000183126
|
si:ch211-219a4.3
|
si:ch211-219a4.3 |
chr15_-_4528326 | 5.72 |
ENSDART00000158122
ENSDART00000155619 ENSDART00000128602 |
tfdp2
|
transcription factor Dp-2 |
chr15_-_20180475 | 5.69 |
ENSDART00000048183
|
exoc3l2b
|
exocyst complex component 3-like 2b |
chr21_+_30306369 | 5.69 |
ENSDART00000145050
ENSDART00000059420 |
lcp2a
|
lymphocyte cytosolic protein 2a |
chr8_-_4586696 | 5.68 |
ENSDART00000143511
ENSDART00000134324 |
gp1bb
|
glycoprotein Ib (platelet), beta polypeptide |
chr5_+_22133153 | 5.68 |
ENSDART00000016214
|
msna
|
moesin a |
chr1_+_36665555 | 5.65 |
ENSDART00000128557
ENSDART00000010632 |
ednraa
|
endothelin receptor type Aa |
chr24_-_31904924 | 5.63 |
ENSDART00000156060
ENSDART00000129741 ENSDART00000154276 |
si:ch73-78o10.1
|
si:ch73-78o10.1 |
chr4_-_13973213 | 5.62 |
ENSDART00000067177
ENSDART00000144127 |
prickle1b
|
prickle homolog 1b |
chr1_+_49510209 | 5.62 |
ENSDART00000052998
|
si:dkeyp-80c12.4
|
si:dkeyp-80c12.4 |
chr18_+_16744307 | 5.60 |
ENSDART00000179872
ENSDART00000133490 |
lyve1b
|
lymphatic vessel endothelial hyaluronic receptor 1b |
chr17_-_37795865 | 5.60 |
ENSDART00000025853
|
zfp36l1a
|
zinc finger protein 36, C3H type-like 1a |
chr16_-_51288178 | 5.55 |
ENSDART00000079864
|
zgc:173729
|
zgc:173729 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.9 | GO:0071236 | cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
3.9 | 11.8 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
3.8 | 15.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
3.5 | 10.5 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
2.9 | 11.8 | GO:0042117 | monocyte activation(GO:0042117) |
2.8 | 8.4 | GO:0006043 | glucosamine metabolic process(GO:0006041) glucosamine catabolic process(GO:0006043) |
2.6 | 7.9 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
2.6 | 15.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
2.5 | 7.4 | GO:0048389 | intermediate mesoderm development(GO:0048389) |
2.4 | 12.1 | GO:1901842 | regulation of high voltage-gated calcium channel activity(GO:1901841) negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
2.3 | 11.5 | GO:2000389 | neutrophil extravasation(GO:0072672) regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
2.2 | 8.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
2.1 | 8.5 | GO:0006116 | NADH oxidation(GO:0006116) glycerol-3-phosphate catabolic process(GO:0046168) |
2.0 | 8.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
2.0 | 7.9 | GO:0045123 | cellular extravasation(GO:0045123) |
1.9 | 15.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
1.9 | 9.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.8 | 3.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
1.8 | 5.4 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
1.7 | 5.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
1.7 | 12.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
1.7 | 5.1 | GO:1990575 | mitochondrial ornithine transport(GO:0000066) mitochondrial L-ornithine transmembrane transport(GO:1990575) |
1.7 | 6.8 | GO:0006598 | polyamine catabolic process(GO:0006598) putrescine catabolic process(GO:0009447) |
1.6 | 4.9 | GO:1905072 | cardiac jelly development(GO:1905072) |
1.4 | 8.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.4 | 5.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.4 | 5.4 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) positive regulation of immunoglobulin production(GO:0002639) |
1.3 | 4.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.2 | 12.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
1.2 | 6.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
1.2 | 8.3 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
1.1 | 11.4 | GO:0051601 | exocyst localization(GO:0051601) |
1.1 | 5.6 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
1.0 | 7.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.0 | 17.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
1.0 | 40.6 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
1.0 | 7.9 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.9 | 5.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.9 | 4.4 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.9 | 8.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.8 | 3.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) ectodermal cell fate specification(GO:0001715) ectodermal cell differentiation(GO:0010668) regulation of ectodermal cell fate specification(GO:0042665) regulation of ectoderm development(GO:2000383) |
0.8 | 3.4 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.8 | 13.3 | GO:0050927 | regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) induction of positive chemotaxis(GO:0050930) |
0.8 | 3.1 | GO:0006272 | leading strand elongation(GO:0006272) |
0.8 | 5.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.8 | 8.3 | GO:0019883 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.7 | 30.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.7 | 2.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.7 | 35.8 | GO:0070830 | apical junction assembly(GO:0043297) bicellular tight junction assembly(GO:0070830) |
0.7 | 5.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.7 | 7.6 | GO:0001541 | ovarian follicle development(GO:0001541) ovulation cycle process(GO:0022602) ovulation cycle(GO:0042698) |
0.7 | 1.3 | GO:0003091 | renal water homeostasis(GO:0003091) renal water transport(GO:0003097) |
0.7 | 2.0 | GO:0003071 | renal system process involved in regulation of blood volume(GO:0001977) renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) regulation of glomerular filtration(GO:0003093) |
0.7 | 4.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 53.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.6 | 5.6 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.6 | 6.8 | GO:0006797 | polyphosphate metabolic process(GO:0006797) polyphosphate catabolic process(GO:0006798) |
0.6 | 6.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.6 | 6.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.6 | 4.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.6 | 4.6 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.6 | 2.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.6 | 8.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.6 | 2.2 | GO:0090155 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.6 | 28.3 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.6 | 12.7 | GO:0030183 | B cell differentiation(GO:0030183) |
0.5 | 2.2 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.5 | 3.6 | GO:0034341 | response to interferon-gamma(GO:0034341) cellular response to interferon-gamma(GO:0071346) |
0.5 | 8.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.5 | 4.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.5 | 6.1 | GO:0051122 | lipoxygenase pathway(GO:0019372) linoleic acid metabolic process(GO:0043651) hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.5 | 7.9 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.5 | 2.9 | GO:0070254 | mucus secretion(GO:0070254) |
0.5 | 2.0 | GO:0098751 | bone cell development(GO:0098751) |
0.5 | 3.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.5 | 18.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 9.4 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.5 | 7.3 | GO:0001843 | neural tube closure(GO:0001843) |
0.4 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 2.2 | GO:0045822 | negative regulation of heart contraction(GO:0045822) negative regulation of blood circulation(GO:1903523) |
0.4 | 4.0 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.4 | 2.2 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.4 | 9.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 2.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 8.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.4 | 32.3 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.4 | 5.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) blood vessel lumenization(GO:0072554) |
0.4 | 2.0 | GO:0048903 | anterior lateral line neuromast hair cell differentiation(GO:0048903) |
0.4 | 8.3 | GO:0002761 | regulation of myeloid leukocyte differentiation(GO:0002761) |
0.4 | 5.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.4 | 5.8 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
0.4 | 1.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 2.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.4 | 2.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.4 | 1.5 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.4 | 4.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 8.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 5.5 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 5.4 | GO:0035778 | pronephric nephron tubule epithelial cell differentiation(GO:0035778) cell differentiation involved in pronephros development(GO:0039014) |
0.4 | 33.2 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
0.4 | 5.0 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 3.2 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
0.3 | 25.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.3 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 2.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 7.7 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.3 | 24.7 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.3 | 6.2 | GO:0001841 | neural tube formation(GO:0001841) |
0.3 | 3.2 | GO:0035479 | angioblast cell migration from lateral mesoderm to midline(GO:0035479) |
0.3 | 4.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 2.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 9.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 6.8 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.3 | 4.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 0.8 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) messenger ribonucleoprotein complex assembly(GO:1990120) |
0.3 | 1.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.3 | 1.8 | GO:0001938 | regulation of endothelial cell proliferation(GO:0001936) positive regulation of endothelial cell proliferation(GO:0001938) |
0.3 | 3.7 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 1.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 4.4 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.2 | 3.7 | GO:0002574 | thrombocyte differentiation(GO:0002574) |
0.2 | 0.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 0.9 | GO:0034164 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.2 | 2.3 | GO:0031274 | pseudopodium organization(GO:0031268) pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 2.9 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 4.5 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 7.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 1.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 6.6 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) |
0.2 | 0.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 9.0 | GO:0045010 | actin nucleation(GO:0045010) |
0.2 | 1.6 | GO:0006203 | dGTP catabolic process(GO:0006203) purine nucleoside triphosphate catabolic process(GO:0009146) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) dGTP metabolic process(GO:0046070) |
0.2 | 8.7 | GO:0050727 | regulation of inflammatory response(GO:0050727) |
0.2 | 1.0 | GO:0097355 | protein localization to heterochromatin(GO:0097355) |
0.2 | 4.4 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.2 | 1.9 | GO:0051893 | cell-substrate adherens junction assembly(GO:0007045) adherens junction assembly(GO:0034333) focal adhesion assembly(GO:0048041) regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.2 | 3.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 3.7 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.2 | 2.4 | GO:0003313 | heart rudiment development(GO:0003313) |
0.2 | 3.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 8.2 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.2 | 1.7 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 16.4 | GO:0031101 | fin regeneration(GO:0031101) |
0.2 | 2.0 | GO:0060021 | palate development(GO:0060021) |
0.2 | 6.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 3.5 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
0.2 | 3.8 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 4.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 5.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 1.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 13.5 | GO:0008064 | regulation of actin polymerization or depolymerization(GO:0008064) regulation of actin filament length(GO:0030832) |
0.1 | 7.6 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 10.7 | GO:0001817 | regulation of cytokine production(GO:0001817) |
0.1 | 1.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 1.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 37.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 1.8 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.1 | 0.8 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 3.7 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 1.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 11.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 1.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 4.2 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 3.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 2.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.2 | GO:0042306 | regulation of protein import into nucleus(GO:0042306) negative regulation of protein import into nucleus(GO:0042308) negative regulation of nucleocytoplasmic transport(GO:0046823) negative regulation of protein localization to nucleus(GO:1900181) regulation of protein import(GO:1904589) negative regulation of protein import(GO:1904590) |
0.1 | 4.3 | GO:0030336 | negative regulation of cell migration(GO:0030336) negative regulation of cell motility(GO:2000146) |
0.1 | 5.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 3.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 2.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 3.5 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 9.7 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 3.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.7 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 1.0 | GO:0098508 | endothelial to hematopoietic transition(GO:0098508) |
0.1 | 2.8 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 5.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 16.5 | GO:0045087 | innate immune response(GO:0045087) |
0.1 | 4.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 7.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.5 | GO:0048798 | swim bladder maturation(GO:0048796) swim bladder inflation(GO:0048798) |
0.1 | 1.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 2.4 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 19.8 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 1.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 2.6 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
0.1 | 5.6 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 1.3 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 2.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 2.3 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 5.7 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 5.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 3.0 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 4.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 1.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 1.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 4.1 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.1 | 2.8 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.1 | 1.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 17.3 | GO:0006955 | immune response(GO:0006955) |
0.1 | 1.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 2.3 | GO:0030149 | sphingolipid catabolic process(GO:0030149) membrane lipid catabolic process(GO:0046466) |
0.1 | 4.9 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.8 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.1 | 3.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 3.4 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.0 | 2.3 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.0 | 0.8 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 3.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 5.6 | GO:0001525 | angiogenesis(GO:0001525) |
0.0 | 1.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 1.7 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.0 | 1.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.3 | GO:0019430 | response to superoxide(GO:0000303) response to oxygen radical(GO:0000305) removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 5.6 | GO:0051301 | cell division(GO:0051301) |
0.0 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 1.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.3 | GO:0042396 | phosphagen metabolic process(GO:0006599) phosphocreatine metabolic process(GO:0006603) phosphagen biosynthetic process(GO:0042396) phosphocreatine biosynthetic process(GO:0046314) |
0.0 | 1.4 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 0.1 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.0 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 1.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
0.0 | 1.1 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 1.5 | GO:0001503 | ossification(GO:0001503) |
0.0 | 1.1 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 1.3 | GO:0043410 | positive regulation of MAPK cascade(GO:0043410) |
0.0 | 0.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 4.8 | GO:0000226 | microtubule cytoskeleton organization(GO:0000226) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 33.8 | GO:0045095 | keratin filament(GO:0045095) |
2.9 | 8.8 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
2.9 | 5.8 | GO:0001891 | phagocytic cup(GO:0001891) |
2.5 | 12.4 | GO:0097433 | dense body(GO:0097433) |
2.0 | 7.9 | GO:0016600 | flotillin complex(GO:0016600) |
1.9 | 15.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.8 | 7.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.8 | 10.8 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
1.7 | 15.2 | GO:0031526 | brush border membrane(GO:0031526) |
1.6 | 9.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.2 | 3.6 | GO:0034709 | methylosome(GO:0034709) |
1.2 | 4.7 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
1.0 | 13.4 | GO:0002102 | podosome(GO:0002102) |
0.8 | 6.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 12.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.7 | 8.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 2.4 | GO:0035301 | Hedgehog signaling complex(GO:0035301) |
0.6 | 8.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.6 | 2.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 1.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 2.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.5 | 2.1 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.5 | 8.8 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.5 | 1.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.5 | 1.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.5 | 6.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 56.1 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.4 | 7.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 2.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 11.3 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 44.4 | GO:0005884 | actin filament(GO:0005884) |
0.4 | 19.6 | GO:0030496 | midbody(GO:0030496) |
0.4 | 2.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 1.0 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.3 | 1.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 8.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 22.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 3.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 3.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 29.6 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 13.7 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.3 | 4.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 0.8 | GO:1990879 | CST complex(GO:1990879) |
0.3 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.9 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 1.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.3 | 1.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 4.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 17.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 11.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 3.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 4.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 3.5 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 53.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 22.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 14.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 3.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 1.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 1.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 4.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 9.5 | GO:0022626 | cytosolic large ribosomal subunit(GO:0022625) cytosolic ribosome(GO:0022626) |
0.2 | 0.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 2.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.7 | GO:0070390 | transcription export complex 2(GO:0070390) |
0.1 | 1.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.7 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.1 | 6.6 | GO:0016529 | sarcoplasm(GO:0016528) sarcoplasmic reticulum(GO:0016529) |
0.1 | 15.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.4 | GO:0016282 | eukaryotic 43S preinitiation complex(GO:0016282) |
0.1 | 7.9 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 1.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 8.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 6.0 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 8.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 6.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 96.5 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 3.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 2.7 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.0 | 7.8 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.4 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.0 | 2.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 5.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 10.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 2.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 4.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 2.2 | GO:0014069 | postsynaptic density(GO:0014069) |
0.0 | 1.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 1.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 3.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 1.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.9 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
3.6 | 50.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.9 | 8.8 | GO:0019767 | immunoglobulin receptor activity(GO:0019763) IgE receptor activity(GO:0019767) |
2.9 | 11.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.8 | 8.4 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
2.8 | 14.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
2.6 | 12.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
2.5 | 12.4 | GO:0098973 | structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
2.4 | 7.3 | GO:0043185 | vascular endothelial growth factor receptor 3 binding(GO:0043185) |
2.3 | 7.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.2 | 15.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
2.1 | 8.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.9 | 5.8 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
1.9 | 11.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.8 | 16.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.8 | 10.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.7 | 12.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.7 | 17.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
1.6 | 11.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.4 | 8.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.4 | 4.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.2 | 5.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
1.2 | 6.1 | GO:0019865 | IgE binding(GO:0019863) immunoglobulin binding(GO:0019865) |
1.2 | 6.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.2 | 6.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.1 | 4.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.0 | 3.1 | GO:0045545 | syndecan binding(GO:0045545) |
1.0 | 14.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.0 | 3.0 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) calcitonin gene-related peptide receptor activity(GO:0001635) |
1.0 | 6.8 | GO:0019809 | spermidine binding(GO:0019809) |
1.0 | 15.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.9 | 12.2 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.9 | 58.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.9 | 5.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.8 | 9.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.8 | 5.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) |
0.8 | 6.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 7.3 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 10.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 2.8 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) |
0.7 | 4.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 3.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 1.9 | GO:0015462 | protein-transmembrane transporting ATPase activity(GO:0015462) |
0.6 | 6.8 | GO:0004309 | exopolyphosphatase activity(GO:0004309) |
0.6 | 5.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 2.3 | GO:0008117 | sphinganine-1-phosphate aldolase activity(GO:0008117) |
0.5 | 6.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 1.6 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 8.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) |
0.5 | 3.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.5 | 1.4 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.5 | 1.9 | GO:0032034 | myosin head/neck binding(GO:0032028) myosin II head/neck binding(GO:0032034) myosin II heavy chain binding(GO:0032038) |
0.5 | 1.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.5 | 1.9 | GO:0047611 | acetylspermidine deacetylase activity(GO:0047611) |
0.5 | 1.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 12.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 53.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 36.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 3.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 8.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 7.7 | GO:0072542 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
0.4 | 3.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 5.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 6.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 3.0 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 1.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.4 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 2.9 | GO:0008515 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 3.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 5.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 6.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 8.7 | GO:0015379 | cation:chloride symporter activity(GO:0015377) potassium:chloride symporter activity(GO:0015379) |
0.3 | 7.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 2.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 3.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 11.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 6.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 1.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 2.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 33.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 9.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 0.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 9.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.6 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 12.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 7.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 2.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 7.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 3.3 | GO:0031682 | G-protein gamma-subunit binding(GO:0031682) |
0.2 | 2.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 2.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 3.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 3.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 8.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 8.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 2.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 28.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 60.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 4.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 1.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 8.5 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.8 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
0.2 | 6.0 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 1.3 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 1.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 2.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 2.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 28.1 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 1.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 70.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 1.7 | GO:0019210 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.1 | 6.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.6 | GO:0070035 | ATP-dependent DNA helicase activity(GO:0004003) ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 2.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 1.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 1.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 1.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 3.1 | GO:0004697 | protein kinase C activity(GO:0004697) calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 1.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 2.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 7.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 5.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 37.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 2.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 3.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 1.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.1 | 25.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 2.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.8 | GO:0035925 | AU-rich element binding(GO:0017091) mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 1.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 20.6 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.1 | 4.2 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.1 | 4.3 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 6.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 6.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 3.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 4.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 3.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 2.8 | GO:0051427 | hormone receptor binding(GO:0051427) |
0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 1.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 9.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 7.0 | GO:0042277 | peptide binding(GO:0042277) |
0.0 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 1.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 1.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 1.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 1.1 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 3.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 1.0 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleoside transmembrane transporter activity(GO:0015211) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 1.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 1.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 8.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.1 | 33.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.0 | 2.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.8 | 10.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.7 | 10.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 6.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 21.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 2.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.5 | 3.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 24.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 5.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 6.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 10.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 6.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 11.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 24.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 6.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 8.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 1.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 7.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 5.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 3.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 6.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 16.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 2.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 2.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 9.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 7.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 2.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 2.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 2.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 5.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 4.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 6.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 6.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 2.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 5.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 2.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 2.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 6.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 12.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 4.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.2 | 6.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.2 | 7.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.2 | 5.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.1 | 5.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.1 | 6.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.0 | 8.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.9 | 11.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.8 | 13.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.8 | 6.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.8 | 6.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.7 | 7.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.7 | 5.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 3.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 5.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 3.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 3.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 8.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 20.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 2.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 5.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 2.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 4.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 3.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 31.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 3.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 4.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 4.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 3.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 17.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 3.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 3.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 3.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 4.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 6.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 2.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 7.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 4.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 9.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 2.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 5.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 2.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 4.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 2.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 2.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 2.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.4 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME S PHASE | Genes involved in S Phase |